ArticleJournal of diabetes and metabolic disorders2026
Serum periostin as a novel biomarker of metabolic and atherogenic risk in newly diagnosed type 2 diabetes mellitus with dyslipidemia.
Abeer Abass Jafer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.